This is the sixth update of a rapid risk assessment originally produced on 9 August 2018. The update addresses the impact of active chains of Ebola virus disease (EVD) transmission reported outside the outbreak’s epicentre, specifically in Goma, a provincial capital in the Democratic Republic of the Congo (DRC).
This is the fifth update of a rapid risk assessment originally produced on 9 August 2018. This rapid risk assessment addresses the potential public health impact of Ebola virus disease for EU/EEA countries and assesses the likelihood of international expansion.
This is the fourth update of a rapid risk assessment originally produced on 9 August 2018. This rapid risk assessment addresses the public health risk associated with the current Ebola virus outbreak in the DRC and its implications for EU/EEA citizens. It was triggered by an increase of EVD transmission in the affected areas over recent weeks, the persistent occurrence of new cases among contacts unknown at the time of EVD diagnosis, the occurrence of a substantial number of cases outside of the ring vaccination contacts and current challenges for the prevention and control of EVD.
The ECDC Communicable Disease Threats Report (CDTR) is a weekly bulletin for epidemiologists and health professionals on active public health threats. This issue covers the period from 3-9 March 2019 and includes updates on Leishmaniasis and Zika virus disease, Middle East respiratory syndrome coronavirus (MERS-CoV), measles, Ebola virus disease, influenza, Rift Valley fever and mass gathering for Carnival in Brazil.
This rapid risk assessment addresses the public health risk associated with the current Ebola virus outbreak in the Democratic Republic of the Congo (DRC) and its implications for EU/EEA citizens.
The ECDC Communicable Disease Threats Report (CDTR) is a weekly bulletin for epidemiologists and health professionals on active public health threats. This issue covers the period from 3-9 February 2019 and includes updates on poliomyelitis, Middle East respiratory syndrome coronavirus (MERS-CoV), measles, Ebola virus disease, influenza, Salmonella Poona and Andes Hantavirus Pulmonary Syndrome.